A study published in the Journal of the American College of Cardiology warns that skipping breakfast significantly increases the risk of death from cardiovascular disease, stroke, and other health issues, emphasizing the importance of eating breakfast for long-term health benefits.
A Danish study suggests that being very thin (BMI below 18.5) significantly increases the risk of early death, while being overweight does not necessarily raise mortality risk, challenging traditional views on BMI and health. The findings highlight that BMI is an imperfect measure and that health is influenced by multiple factors beyond weight.
A recent report reveals that three-quarters of U.S. adults are now classified as overweight or obese, highlighting a significant public health concern.
The FDA has approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight and at least one weight-related condition. Zepbound activates receptors in the intestine to reduce appetite and food intake. It is administered once weekly via injection and has been shown to significantly reduce body weight in clinical trials. However, it can cause side effects such as nausea and diarrhea. Zepbound should not be used in patients with a history of medullary thyroid cancer or severe gastrointestinal disease. It should also not be used in combination with certain medications.
A new study suggests that being overweight, as defined by the body mass index (BMI), may not be associated with an increased risk of early death when considered separately from other health issues. The study found that BMI is a poor indicator of mortality risk and should be supplemented with additional measures such as waist circumference and weight trajectory. However, experts caution that the study's limitations make it difficult to determine if the findings are solely due to BMI or other factors. They also emphasize that excess weight is still linked to a higher risk of developing multiple health conditions, which can adversely affect quality of life.
Morgan Stanley has upgraded several stocks to overweight, indicating that they believe these stocks will outperform the market. The investment bank's market analysis has led them to recommend these stocks as good investment opportunities.